Company / Interest Expense
MEDICINOVA INC Interest Expense History
FY2011-FY2014 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$628
FY2014
5-year range
-
FY2011-FY2014
Trend
-
vs FY2013
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $2M to $628 over the past 3 years.
Based on SEC 10-K filings.
$628 in FY2014.
Improved from $2M to $628 over the past 3 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -92.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -92.7%, indicating a declining trend.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2014 | $628 | - |
| FY2013 | - | - |
| FY2012 | $1.6M | +0.0% |
| FY2011 | $1.6M | - |
As of FY2014 · SEC 10-K · Updated Jun 28, 2026